Sommadossi Jean-Pierre 13D and 13G filings for Atea Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:30 pm Purchase | 2023-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Sommadossi Jean-Pierre | 8,162,914 9.600% | 688,032 (+9.20%) | Filing |
| 2023-02-10 4:15 pm Purchase | 2022-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Sommadossi Jean-Pierre | 7,474,882 8.800% | 374,883 (+5.28%) | Filing |
| 2022-02-10 4:15 pm Purchase | 2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Sommadossi Jean-Pierre | 7,099,999 8.400% | 298,335 (+4.39%) | Filing |
| 2021-02-10 4:31 pm Purchase | 2020-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Sommadossi Jean-Pierre | 6,801,664 8.200% | 6,801,664 (New Position) | Filing |